Akdital S.A (CBSE:AKT)

Morocco · Delayed Price · Currency is MAD

1,178.00

+7.00 (0.60%)

At close: Jun 26, 2026

-19.86% (1Y)

Market Cap	16.68B -18.8%
Revenue (ttm)	4.41B +49.4%
Net Income	443.68M +41.0%
EPS	n/a
Shares Out	14.16M
PE Ratio	37.59
Forward PE	25.53
Dividend	14.00 (1.19%)
Ex-Dividend Date	Jul 24, 2025

Volume	797
Open	1,172.00
Previous Close	1,171.00
Day's Range	1,167.00 - 1,178.00
52-Week Range	975.00 - 1,623.00
Beta	-0.12
Analysts	Strong Buy
Price Target	1,678.50 (+42.49%)
Earnings Date	Jul 2, 2026

About Akdital S.A

Akdital S.A operates in the healthcare sector in Morocco. The company offers its services in the areas of surgical, interventional medicine, critical and intensive care, maternity care, oncology, and diagnostic. It operates private hospitals, multidisciplinary, and specialized clinics and oncology centers. The company was founded in 2011 and is headquartered in Casablanca, Morocco. [Read more]

Industry Hospitals

Founded 2011

Employees 3,907

Stock Exchange Casablanca Stock Exchange

Ticker Symbol AKT

Full Company Profile

Financial Performance

In 2025, Akdital S.A's revenue was 4.41 billion, an increase of 49.40% compared to the previous year's 2.95 billion. Earnings were 443.68 million, an increase of 41.03%.

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for AKT stock is "Strong Buy." The 12-month stock price target is MAD 1,679, which is an increase of 42.49% from the latest price.

Price Target

MAD 1,679

(42.49% upside)

Analyst Consensus: Strong Buy

Stock Forecasts